Attenuation of corneal myofbroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer

Molecular Vision

Volumn 18, Issue , 2012, Pages 2598-2607

  Sharma, Ajay ^a,b   Rodier, Jason T ^a,b   Tandon, Ashish ^a,b   Klibanov, Alexander M ^c,d   Mohan, Rajiv R ^a,b,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Massachusetts Institute of Technology Cambridge   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN FC FRAGMENT; LIPOFECTAMINE; MESSENGER RNA; NANOPARTICLE; NITROGEN; PHOSPHATE; POLYETHYLENEIMINE; SOLUBLE TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; ACTA2 PROTEIN, HUMAN; ACTIN; LIPID; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CORNEA FIBROSIS; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE DOSAGE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MYOFIBROBLAST; NICK END LABELING; NONVIRAL GENE DELIVERY SYSTEM; OCULAR FIBROSIS; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; SOLUBLE TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2 GENE; TOXICITY TESTING; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CORNEA; DRUG EFFECT; FIBROSIS; GENETIC TRANSFECTION; GENETICS; METHODOLOGY; PATHOLOGY; PLASMID; SOLUBILITY;

ACTINS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CORNEA; FIBROSIS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; LIPIDS; MYOFIBROBLASTS; NANOPARTICLES; PLASMIDS; POLYETHYLENEIMINE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SOLUBILITY; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84869227933     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Herranz F, Almarza E, Rodríguez I, Salinas B, Rosell Y, Desco M, Bulte JW, Ruiz-Cabello J. The application of nanopar-ticles in gene therapy and magnetic resonance imaging. Microsc Res Tech 2011; 74:577-591. [PMID: 21484943].
2. Zarbin MA, Montemagno C, Leary JF, Ritch R. Nanomedicine in ophthalmology: the new frontier. Am J Ophthalmol 2010; 150:144-162: [PMID: 20670739].
3. Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 2010; 29:596-609. [PMID: 20826225].
4. Jin S, Leach JC, Ye K. Nanoparticle-mediated gene delivery. Methods Mol Biol 2009; 544:547-557. [PMID: 19488722].
5. Jani PD, Singh N, Jenkins C, Raghava S, Mo Y, Amin S, Kompella UB, Ambati BK.Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis. Invest Ophthalmol Vis Sci 2007; 48:2030-2036. [PMID: 174 6 0 257].
6. Sharma A, Tandon A, Tovey JC, Gupta R, Robertson JD, Fortune JA, Klibanov AM, Cowden JW, Rieger FG, Mohan RR. Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea. Nanomedi-cine 2011; 7:505-513. [PMID: 21272669].
7. Mohan RR, Tovey JC, Sharma A, Tandon A. Gene therapy in the Cornea: 2005-present. Prog Retin Eye Res 2012; 31:43-64. [PMID: 21967960].
8. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999; 60:149-160. [PMID: 10 42 5321].
9. Lai WF. In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives. Expert Rev Med Devices 2011; 8:173-185. [PMID: 21381910].
10. Jere D, Jiang HL, Arote R, Kim YK, Choi YJ, Cho MH, Akaike T, Cho CS. Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv 2009; 6:827-834. [PMID: 19558333].
11. Wightman L, Kircheis R, Rössler V, Carotta S, Ruzicka R, Kursa M, Wagner E. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 2001; 3:362-372. [PMID: 11529666].
12. Intra J, Salem AK. Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Release 2008; 130:129-138. [PMID: 18538436].
13. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005; 7:657-663. [PMID: 15543529].
14. Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci USA 2005; 102:5679-5684. [PMID: 15824322].
15. Louis MH, Dutoit S, Denoux Y, Erbacher P, Deslandes E, Behr JP, Gauduchon P, Poulain L. Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice. Cancer Gene Ther 2006; 13:367-374. [PMID: 161670 6 4].
16. Netto MV, Mohan RR, Ambrósio R Jr, Hutcheon AE, Zieske JD, Wilson SE. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea 2005; 24:509-522. [PMID: 15968154].
17. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res 1999; 18:311-356. [PMID: 10192516].
18. Yamanaka O, Liu CY, Kao WW. Fibrosis in the anterior segments of the eye. Endocr Metab Immune Disord Drug Targets 2010; 10:331-335. [PMID: 2 0 9 25 651].
19. Myrna KE, Pot SA, Murphy CJ. Meet the corneal myofibroblast: the role of myofibroblast transformation in corneal wound healing and pathology. Vet Ophthalmol 2009; 12:Suppl 125-127. [PMID: 19891648].
20. Long Q, Chu R, Zhou X, Dai J, Chen C, Rao SK, Lam DS. Correlation between TGF beta1 in tears and corneal haze following LASEK and epi-LASIK. J Refract Surg 2006; 22:708-712. [PMID: 16995554].
21. Tandon A, Tovey JC, Sharma A, Gupta R, Mohan RR. Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med 2010; 10:565-578. [PMID: 20642439].
22. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of alpha-smooth muscle actin expression and myofibro-blast transfor mation in cultured corneal keratocytes. Cor nea 1996; 15:505-516. [PMID: 8862928].
23. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991; 32:2441-2454. [PMID: 165129 6].
24. Fini ME, Girard MT, Matsubara M, Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthalmol Vis Sci 1995; 36:622-633. [PMID: 7890493].
25. Jester JV, Barry-Lane PA, Petroll WM, Olsen DR, Cavanagh HD. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea 1997; 16:177-187. [PMID: 9 0 71 531]
26. Mohan RR, Tovey JC, Gupta R, Sharma A, Tandon A. Decorin biology, expression, function and therapy in the cornea. Curr Mol Med 2011; 11:110-128. [PMID: 21342131].
27. Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, York-Defalco C, Dean NM, Schultz GS, Khaw PT. Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome. Gene Ther 2003; 10:59-71. [PMID: 12525838].
28. Sharma A, Mehan MM, Sinha S, Cowden JW, Mohan RR. Trichostatin A inhibits corneal haze in vitro and in vivo. Invest Ophthalmol Vis Sci 2009; 50:2695-2701. [PMID: 19168895].
29. Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res 2010; 91:238-245. [PMID: 20546727].
30. Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu ZY, Green J, Anver MR, Merlino G, Wakefield LM. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J Clin Invest 2002; 109:1607-1615. [PMID: 12070308].
31. Fortune JA, Novobrantseva TI, Klibanov AM. Highly effective gene transfection in vivo by alkylated polyethylenimine. J Drug Deliv 2011; 2011:204058 [PMID: 21490747].
32. Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1999; 55:465-475. [PMID: 9 9 870 71].
33. Xin J, Homma T, Matsusaka T, Ma J, Isaka Y, Imai E, Ichikawa I. Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein. Transplantation 2004; 77:1433-1442. [PMID: 151676 0 3].
34. Yamada M, Kuwano K, Maeyama T, Yoshimi M, Hamada N, Fukumoto J, Egashira K, Hiasa K, Takayama K, Nakanishi Y. Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis. J Clin Pathol 2007; 60:916-920. [PMID: 17018685].
35. Motomura Y, Kanbayashi H, Khan WI, Deng Y, Blennerhassett PA, Margetts PJ, Gauldie J, Egashira K, Collins SM. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta ty pe II receptor gene t ransfer. Am J Physiol Gastrointest Liver Physiol 2005; 288:G143-G150. [PMID: 15297261].
36. Wilson SE, Mohan RR, Mohan RR, Ambrósio R Jr, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001; 20:625-637. [PMID: 11470453].
37. Mohan RR, Hutcheon AE, Choi R, Hong J, Lee J, Mohan RR, Ambrósio R Jr, Zieske JD, Wilson SE. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res 2003; 76:71-87. [PMID: 12589777].